Wang, X., Tsang, E. S., Ellenbogen, Y., Patil, V., Sotov, V., O'Kane, G. M., Knox, J. J., Wang, B. X., Zadeh, G., Chen, E. X. (2026). Correlative analysis of phase II trial of olaparib and durvalumab in patients with IDH -mutated cholangiocarcinoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.4157